[The Role of SOCS in the Development of Tumors]

Chunlai Liu1, Hongyu Liu2, Jun Chen3

  • 1Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin 300052, China.

Insights

Suppressor of cytokine signaling (SOCS) proteins regulate cytokine responses. Their abnormal expression promotes tumor development, making SOCS a potential therapeutic target for cancer treatment.

Area of Science:

  • Molecular Biology
  • Oncology
  • Signal Transduction

Background:

  • Suppressor of cytokine signaling (SOCS) proteins are negative regulators of cytokine signaling pathways.
  • They inhibit Janus kinase-Signal Transducer and Activator of Transcription (JAK-STAT) signaling, controlling cell proliferation, differentiation, and apoptosis.
  • Dysregulation of SOCS proteins is implicated in tumor progression.

Purpose of the Study:

  • To review SOCS family members, their structure, function, and role in tumor development.
  • To highlight SOCS proteins as potential tumor suppressors and therapeutic targets.

Main Methods:

  • Literature review of SOCS family proteins.
  • Analysis of SOCS protein function in cytokine signaling and tumor progression.
  • Examination of molecular mechanisms leading to SOCS dysfunction in cancer.

Main Results:

  • SOCS proteins are crucial negative regulators of JAK-STAT signaling.
  • Aberrant SOCS expression, due to hypermethylation, mutation, or deletion, leads to continuous JAK-STAT activation, promoting tumor growth and metastasis.
  • SOCS proteins function as tumor suppressors.

Conclusions:

  • SOCS proteins are vital in preventing uncontrolled cell growth and metastasis.
  • Targeting SOCS proteins offers a promising new strategy for cancer therapy.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

3.0K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression02:07

Tumor Progression

3.5K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.3K